Programa de Doctorado en Ciencias Químico Biológicas y de la Salud, Universidad de Sonora, Hermosillo, Sonora, Mexico.
Unidad Regional Centro, Departamento de Ciencias, Químico Biológicas y de la Salud, Universidad de Sonora, Blvd. Encinas y Rosales S/N, Hermosillo, Sonora, Mexico.
Mol Divers. 2021 Nov;25(4):2289-2305. doi: 10.1007/s11030-020-10119-w. Epub 2020 Jul 5.
Since the beginning, natural products have represented an important source of bioactive molecules for cancer treatment. Among them, cardenolides attract the attention of different research groups due to their cardiotonic and antitumor activity. The observed biological activity is closely related to their Na/K-ATPase inhibition potency. Currently, the discovery of new compounds against cancer is an urgent need in modern pharmaceutical research. Thus, the aim of this work is to determine the physicochemical properties and substituent effects that module the antiproliferative activity of cardenolides on the human lung cancer cell line A549. We build and curate a library with results obtained from literature; molecular descriptors were calculated in PaDEL software, and SAR/QSAR analysis was performed. The SAR results showed that cardenolides were sensitive to modifications in C and D steroidal ring and required substituent groups with the function of hydrogen bond acceptor at the C3 position. QSAR models to doubly linked-type cardenolides indicated that properties as lipoaffinity and atoms with the capacity to be hydrogen bond acceptors are involved in the increment of antiproliferative activity on A549 cell line. In contrast, the presence and position of very electro-negative atoms on the molecule decreased the antiproliferative effect on A549 cells. These results suggest that the antiproliferative capacity of cardenolides on the cell line A549 is strongly related to substituent groups on the C3 position, which must not be carbohydrate. Additionally, the steroidal rings C and D must remain without modifications.
从一开始,天然产物就代表了癌症治疗中生物活性分子的重要来源。其中,强心苷因其心脏毒性和抗肿瘤活性而引起了不同研究小组的关注。观察到的生物活性与它们对 Na/K-ATP 酶的抑制能力密切相关。目前,发现针对癌症的新化合物是现代药物研究的迫切需要。因此,这项工作的目的是确定调节强心苷对人肺癌细胞系 A549 的增殖活性的物理化学性质和取代基效应。我们构建并整理了一个包含文献结果的库;在 PaDEL 软件中计算了分子描述符,并进行了 SAR/QSAR 分析。SAR 结果表明,强心苷对 C 和 D 甾体环的修饰很敏感,并且需要在 C3 位置具有氢键接受功能的取代基。对双链接型强心苷的 QSAR 模型表明,脂亲和力和能够成为氢键接受体的原子的性质参与了对 A549 细胞系增殖活性的增加。相比之下,分子上存在和位置非常电负性的原子会降低对 A549 细胞的增殖抑制作用。这些结果表明,强心苷对 A549 细胞系的增殖能力与 C3 位置上的取代基密切相关,这些取代基不能是碳水化合物。此外,C 和 D 甾体环必须保持不变。